Psychiatry

Physiatrist Abby Cheng, MD, an author of the AAPM&R Long COVID Mental Health Consensus Guidance Statement, discusses why the symptoms can be confusing.

The risk of cardiovascular disease increased with longer cumulative exposure to ADHD medications, peaking at 3 to 5 years of use, reported researchers.

Individuals assessed for GDM whose time above target level was greater than 10% by CGM measure had a 63% increased risk of poor newborn outcomes.

Nearly half of survey respondents say they are anxious before seeing a doctor and, mainly because the do not have enough information to prepare for the visits.

When a patient is upset, agitated, or potentially violent, being empathetic and respectful are keys to defusing a potentially dangerous situation, says the Crisis Prevention Institute.

Your daily dose of the clinical news you may have missed.

Telehealth use is waning consistently from its peak use during the pandemic, raising the question of what the future holds for virtual care.

Results of a new study showed that greater intake of ultraprocessed foods, particularly artificial sweeteners and artificially sweetened beverages, was linked to a higher risk for depression.

Elevated inflammation, rather than depression, may drive poor weight loss outcomes in patients with obesity following bariatric surgery, suggest authors of new study.

Results from a new study suggest that postnatal SSRI treatment may be beneficial in the long term for both women with postpartum depression and their children.

The US FDA approved zuranolone 50 mg as the first oral, once-daily treatment for postpartum depression in adults.

Gen Z is most likely to use social media to self diagnose and YouTube is the top platform for diagnosis content; there is so much more to learn from this survey.

AspyreRx™, prescribed in 90-day increments, resulted in a mean HbA1c reduction of 1.3% at 180 days in 1 out of 2 phase 3 trial participants. A Q4 launch is anticipated.

Binge drinking among women going through menopause has been on the rise, research indicates, making clinical inquiry in this population particularly important.

Your daily dose of clinical news you may have missed.

The predictive value of loneliness for cardiovascular disease in patients with diabetes was stronger than traditional lifestyle risk factors in large UK Biobank analysis.

The FDA's recommendations serve to inform potential research sponsors on development protocols for psychedelics and to solicit comment from industry.

Your daily dose of clinical news you may have missed.

Primary care clinicians should screen all adults for the 3 mental health conditions to ensure timely referral for appropriate treatment.

Nearly all Americans with health care insurance say rising costs are affecting their mental wellbeing and their physical health, according to new survey findings.

The world's first RSV vaccine and the virus surveillance that is missing, PCPs missing opportunities to treat obesity, T2D linked to subclinical CVD, and more news.

At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.

The AAFP and other national medical groups endorsed the warning from Surgeon General Murthy that social media is fueling the mental health crisis among young Americans.

In a unique pharmacodynamic study, nalmefene demonstrated rapid reversal of respiratory depression from the synthetic opioid remifentanil and sustained duration of action.

Results showed that 37% of adults feel more anxious now than they did 1 year ago.

Brexpiprazole, an atypical antipsychotic, is the first and only medication approved to treat AD-associated agitation, reported in almost half of people with the disease.

In a study of over 1000 children and adolescents, authors identified 4 distinct profiles of psychiatric comorbidity with differing risk for a self-harm event.

Your daily dose of clinical news you may have missed.

Researchers found that reliable improvement of depressive symptoms after psychological therapy was associated with a 12% decrease in CVD risk at any given time.

Persons with long COVID showed compensatory neural activity in certain brain areas while performing memory tasks as long as 6 months after infection resolved.